Systemic ciprofloxacin treatment of multidrug-resistant Aggregatibacter actinomycetemcomitans in severe periodontitis

Diagn Microbiol Infect Dis. 2024 Feb;108(2):116162. doi: 10.1016/j.diagmicrobio.2023.116162. Epub 2023 Dec 15.

Abstract

An adult periodontitis patient treated with mechanical/surgical therapy experienced gingival necrosis and granulomas post-treatment. Aggregatibacter actinomycetemcomitans, a tissue-invasive pathogen, was recovered and multidrug-resistant but susceptible to ciprofloxacin. Systemic ciprofloxacin eliminated A. actinomycetemcomitans with marked clinical improvement. Ciprofloxacin may be prescribed for A. actinomycetemcomitans periodontal infection unresponsive to the common amoxicillin-metronidazole treatment.

Keywords: Aggregatibacter actinomycetemcomitans; Ciprofloxacin; Periodontitis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aggregatibacter actinomycetemcomitans
  • Anti-Bacterial Agents* / therapeutic use
  • Ciprofloxacin / therapeutic use
  • Humans
  • Metronidazole
  • Periodontal Pocket
  • Periodontitis* / drug therapy

Substances

  • Anti-Bacterial Agents
  • Ciprofloxacin
  • Metronidazole